Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid (“DNA”). Using the polymerase chain reaction (“PCR”) to enable both the production and detection of DNA, as of February 13, 2025, we operate in two primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase (“RNAP”) for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.cess.
Management Team
Chief Legal Officer and Executive Director, Business Development, Applied DNA Sciences, and President, LineaRx, Inc.
Stock Information
Shareholder Info – Investor Relations
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, NY 11790
investor@adnas.com | 631.240.8800
Sanjay M. Hurry
Executive Director, Investor Relations and Corporate Communications
sanjay.hurry@adnas.com | M: 917-733-5573
Transfer Agent
American Stock Transfer and Trust Company
6201 15th Ave.
Brooklyn, New York 11219
Tel: 718.921.8210
Fax: 718.921.8355
http://www.amstock.com/main/
For additional information, please click here.
SEC Counsel
.
Applied DNA Sciences is not able to purchase shares on your behalf, and it is not possible for you to purchase shares directly from us. Please contact a stockbroker, bank, or independent financial advisor, who should be able to act on your behalf.
Auditor
Marcum LLP
10 Melville Park Road
Melville, NY 11790
tel: 631 414 4000
fax: 631 414 4001
http://www.marcumllp.com
Board of Directors
Applied DNA’s Board of Directors consists of individuals with proven leadership skills, broad management experience
in
established companies, and their reputation as independent thinkers.
With experience in fields ranging from Bioagriculture to Zoology, the company will continue to benefit from the
Board’s diversity of experience and opinions.
